88 related articles for article (PubMed ID: 23929756)
1. PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis.
Narayan G; Xie D; Freddy AJ; Ishdorj G; Do C; Satwani P; Liyanage H; Clark L; Kisselev S; Nandula SV; Scotto L; Alobeid B; Savage D; Tycko B; O'Connor OA; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2013 Nov; 52(11):1030-41. PubMed ID: 23929756
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma.
Huang W; Xue X; Shan L; Qiu T; Guo L; Ying J; Lu N
BMC Cancer; 2017 Dec; 17(1):815. PubMed ID: 29202805
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of PCDH10 in human prostate cancer cell lines.
Li Z; Li W; Xie J; Wang Y; Tang A; Li X; Ye J; Gui Y; Cai Z
Cell Biol Int; 2011 Jul; 35(7):671-6. PubMed ID: 21314642
[TBL] [Abstract][Full Text] [Related]
5. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q
Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458
[TBL] [Abstract][Full Text] [Related]
6. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells.
Qiu C; Bu X; Jiang Z
Oncol Rep; 2016 Jul; 36(1):383-9. PubMed ID: 27176920
[TBL] [Abstract][Full Text] [Related]
7. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
[TBL] [Abstract][Full Text] [Related]
9. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
10. PCDH10 inhibits cell proliferation of multiple myeloma via the negative regulation of the Wnt/β-catenin/BCL-9 signaling pathway.
Xu Y; Yang Z; Yuan H; Li Z; Li Y; Liu Q; Chen J
Oncol Rep; 2015 Aug; 34(2):747-54. PubMed ID: 26081897
[TBL] [Abstract][Full Text] [Related]
11. Protocadherin-10 is involved in angiogenesis and methylation correlated with multiple myeloma.
Li Y; Yang ZS; Song JJ; Liu Q; Chen JB
Int J Mol Med; 2012 Apr; 29(4):704-10. PubMed ID: 22245948
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphoma.
Daibata M; Nemoto Y; Bandobashi K; Kotani N; Kuroda M; Tsuchiya M; Okuda H; Takakuwa T; Imai S; Shuin T; Taguchi H
Clin Cancer Res; 2007 Jun; 13(12):3528-35. PubMed ID: 17575215
[TBL] [Abstract][Full Text] [Related]
14. A novel wnt regulatory axis in endometrioid endometrial cancer.
Zhao Y; Yang Y; Trovik J; Sun K; Zhou L; Jiang P; Lau TS; Hoivik EA; Salvesen HB; Sun H; Wang H
Cancer Res; 2014 Sep; 74(18):5103-17. PubMed ID: 25085246
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of PCDH10 promoter methylation in patients with bladder transitional cell carcinoma.
Lin YL; Li ZG; Guan TY
Urol Int; 2013; 90(2):219-24. PubMed ID: 23171734
[TBL] [Abstract][Full Text] [Related]
16. Role of PCDH10 and its hypermethylation in human gastric cancer.
Li Z; Chim JC; Yang M; Ye J; Wong BC; Qiao L
Biochim Biophys Acta; 2012 Feb; 1823(2):298-305. PubMed ID: 22206871
[TBL] [Abstract][Full Text] [Related]
17. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
20. PCDH10 is a candidate tumour suppressor gene in medulloblastoma.
Bertrand KC; Mack SC; Northcott PA; Garzia L; Dubuc A; Pfister SM; Rutka JT; Weiss WA; Taylor MD
Childs Nerv Syst; 2011 Aug; 27(8):1243-9. PubMed ID: 21597995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]